Contact Us
Drug Search Results
More Filters [+]

Indobufen

Alternative Names: indobufen
Latest Update: 2024-11-20
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: COX Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Colombia | Czech | Italy | Korea | Mexico | Peru | Portugal | Slovakia

Approved Indications: None

Known Adverse Events: None

Company: Jinhong Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Indobufen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Gastroesophageal Reflux|Esophagitis, Peptic|Coronary Artery Disease|Acute Coronary Syndrome|Ischemic Stroke|Atherosclerosis|Myocardial Ischemia

Phase 3: Atrial Fibrillation|Thromboembolism

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ITAS

N/A

Not yet recruiting

Stroke

2026-12-31

HenanICE202001

N/A

Withdrawn

Myocardial Ischemia|Coronary Artery Disease

2026-12-30

ChiCTR2200055893

N/A

Not yet recruiting

Ischemic Stroke

2026-06-01

OPTION2

P4

Not yet recruiting

Acute Coronary Syndrome|Coronary Artery Disease

2026-05-31

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Indobufen nicht besser als ASS nach Apoplex.

04/11/2024

PubMed

 Indobufen alleviates ischemic stroke injury by regulating transcription factor NRF2 and inhibiting ATG5 expression.

04/02/2024

PubMed

 Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions